Pfizer is raising the price of its covid-19 vaccine in Europe by over 25% under a newly negotiated contract with the European Union, according to a report from the Financial Times. Competitor Moderna is also hiking the price of its vaccine in Europe by roughly 10%.
Pfizer is raising the price of its covid-19 vaccine in Europe by over 25% under a newly negotiated contract with the European Union, according to a report from the Financial Times. Competitor Moderna is also hiking the price of its vaccine in Europe by roughly 10%.
Share this Article
Recommended